Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

This publication has 33 references indexed in Scilit:

• The role of antifungal treatment in hematology
  Haematologica, 2012
• Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study
  International Journal of Infectious Diseases, 2011
• Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT
  Bone Marrow Transplantation, 2010
• Empirical versus Preemptive Antifungal Therapy for High‐Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
  Clinical Infectious Diseases, 2009
• Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
  Clinical Infectious Diseases, 2009
• Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients
  Journal of Clinical Pathology, 2008
• A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT
  Bone Marrow Transplantation, 2008
• Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
  Clinical Infectious Diseases, 2005
• Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients
  The Journal of Infectious Diseases, 2002
• 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
  Clinical Infectious Diseases, 2002